The Partnership is governed by a joint Steering Committee of research and administrative leaders from both institutions.


Jakub Tolar, M.D., Ph.D.


J Tolar 4x5 300 dpiDr. Jakub Tolar is dean of the Medical School and vice president ad interim for health sciences at the University of Minnesota. A pediatric blood and marrow transplant physician whose life work centers on helping children with devastating genetic disorders, Dr. Tolar is a clinician-researcher whose efforts span both the clinic and the laboratory. He is known for his ground-breaking use of bone marrow transplant to treat severe forms of the devastating skin disorder epidermolysis bullosa. His laboratory is currently working with state-of-the-art gene-editing technologies to repair genetic errors in a patient’s own cells and use the corrected cells for transplant and other therapies. Dr. Tolar is a Distinguished McKnight Professor and co-chairs Regenerative Medicine Minnesota, a state-funded program funding research, biotechnology, and education to support development of regenerative medicine infrastructure in the state.

Gregory J. Gores, M.D.


Gregory-Gores-10017623Gregory J. Gores, M.D. is a Reuben R. Eisenberg Endowed Professor of Medicine and Physiology. He is also Executive Dean for Research at Mayo Clinic, a Distinguished Investigator of the Mayo Foundation, and a past chair of the Division of Gastroenterology and Hepatology.  His clinical and research contributions include advances in our understanding of hepatobiliary malignancies, liver transplantation and mechanisms of liver cell injury. He is the past recipient of a highly prestigious and competitive NIH MERIT Award, currently a Principal Investigator of three NIH R01 grants. He has co-authored more than 500 total publications which have been cited over 25,000 times.

Tucker LeBien, Ph.D.

Program Director

tucker-lebienDr. Tucker LeBien serves as the Medical School’s vice dean for research, associate vice president for research at the Academic Health Center, and professor in the department of Laboratory Medicine and Pathology at the University of Minnesota. LeBien oversees interdisciplinary research centers, shared resources that provide critical technologies for research faculty, and research compliance and space allocation across the University’s health sciences. As an immunologist, LeBien is a recognized leader in human lymphocyte (blood-cell) development.

Eric Wieben

Program Director

eric-wiebenDr. Eric Wieben is the director of Mayo Clinic Genomics Research Center, professor of Biochemistry and Molecular Biology at Mayo Clinic College of Medicine, and the Mayo project leader of the Minnesota Partnership for Biotechnology and Medical Genomics. Dr. Wieben is on the Board of Directors of the BioBusiness Alliance of Minnesota, an industry lead non-profit group that is working to develop biotechnology business ventures. Dr. Wieben’s research efforts are focused in the area of pharmacogenomics: determining how individual genetic differences influence response to drug treatment.